Cherie P Erkmen, Ryan F Moore, Clifford Belden, Verdi DiSesa, Larry R Kaiser, Grace X Ma, Anuradha Paranjape
{"title":"Overcoming Barriers to Lung Cancer Screening by Implementing a Single-Visit Patient Experience.","authors":"Cherie P Erkmen, Ryan F Moore, Clifford Belden, Verdi DiSesa, Larry R Kaiser, Grace X Ma, Anuradha Paranjape","doi":"10.15436/2377-0902.17.1469","DOIUrl":null,"url":null,"abstract":"In 2011 the authors of the National Lung Screening Trial (NLST) reported a 20% risk reduction of lung cancer death using annual screening with a low dose CT (LDCT)[1]. In 2013, the United States Preventative Services Task Force (USPSTF) gave lung cancer screening a grade B recommendation indicating that LDCT should be covered by private insurers without cost sharing (co-pay)[2]. Implementation of a screening program could potentially avert 12,000 deaths annually[3]. Unfortunately, implementation of lung cancer screening programs has been slower than expected. Despite evidence that USPSTF recommendations influence 88.4% of practicing primary care providers (PCP’s)[4], only 47% of PCPs acknowledged the lung cancer screening recommendation[5], and only 12% of PCPs in an academic setting used LDCT scan for lung cancer screening[6]. The reasons for the failure to generate enthusiasm to implement lung cancer screening are multifactorial. However, lung cancer screening provides an opportunity to design novel patient-centered care. In this discussion, we will explore both the barriers to lung cancer screening implementation and our multidisciplinary approach which prioritizes patient-centered care by creating a single-visit patient experience.","PeriodicalId":91089,"journal":{"name":"International journal of cancer and oncology","volume":"4 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796669/pdf/","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cancer and oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15436/2377-0902.17.1469","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/5/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8
Abstract
In 2011 the authors of the National Lung Screening Trial (NLST) reported a 20% risk reduction of lung cancer death using annual screening with a low dose CT (LDCT)[1]. In 2013, the United States Preventative Services Task Force (USPSTF) gave lung cancer screening a grade B recommendation indicating that LDCT should be covered by private insurers without cost sharing (co-pay)[2]. Implementation of a screening program could potentially avert 12,000 deaths annually[3]. Unfortunately, implementation of lung cancer screening programs has been slower than expected. Despite evidence that USPSTF recommendations influence 88.4% of practicing primary care providers (PCP’s)[4], only 47% of PCPs acknowledged the lung cancer screening recommendation[5], and only 12% of PCPs in an academic setting used LDCT scan for lung cancer screening[6]. The reasons for the failure to generate enthusiasm to implement lung cancer screening are multifactorial. However, lung cancer screening provides an opportunity to design novel patient-centered care. In this discussion, we will explore both the barriers to lung cancer screening implementation and our multidisciplinary approach which prioritizes patient-centered care by creating a single-visit patient experience.